Dr. Reddy’s Laboratories’ Q1FY23 Quarter Results
Dr. Reddy’s Laboratories reported 20% YoY revenue growth
- 28 Jul 2022
- Dr. Reddy’s Laboratories reported 9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended June (Q1FY23). On a year-on-year (YoY) basis, it witnessed a growth of 20%.
- Its expenses for the quarter were down by 13% QoQ and up by 3% YoY.
- The pharma major reported a net profit of Rs 1,189 crores in Q1FY23 as against a net profit of Rs 380 crores in Q1FY22.
- The earnings per share (EPS) of Dr. Reddy’s Laboratories stood at 71.5 during Q1FY23..
Dr. Reddy’s Laboratories’ Financial Statements for Q1FY23:
Total Income | 5,053 | 5,597 | 6,087 | 9% | 20% |
Total Expenses | 4,514 | 5,348 | 4,628 | -13% | 3% |
Profit before tax | 556 | 259 | 1,468 | 467% | 164% |
Tax | 175 | 162 | 279 | 72% | 59% |
Profit after tax | 380 | 97 | 1,189 | 1126% | 213% |
Earnings per share | 23.0 | 5.8 | 71.5 |
Data Source: BSE, Company announcements
Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Open Demat Account
Open Demat Account